UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	January 30, 2014 4:00 P.M.

Form:	S-1
CIK: 0001515673 Company Name: Ultragenyx Pharmaceutical Inc. File Number: 333-192244